<DOC>
	<DOCNO>NCT02404285</DOCNO>
	<brief_summary>This 12 week , multi-site , double-blind , vehicle-controlled study subject mild moderate facial acne . Subjects randomize 1:1 apply either topical NAG vehicle gel daily . Subjects evaluate clinical acne quality life outcome baseline , 2 week , 4 week , 8 week 12 week .</brief_summary>
	<brief_title>A Study Evaluate Clinical Effect Daily Next Scienceâ„¢ Acne Gel ( NAG ) Mild Moderate Facial Acne</brief_title>
	<detailed_description>Sample Size : N= 60 complete subject Male female subject 12 year old diagnose mild moderate inflammatory facial acne vulgaris . Subjects treat daily topical NAG match vehicle attend screening , randomization , 2,4,8 12 week visit . The follow assess : 1 . Lesion count photography 2 . Investigator Global Assessment 3 . Acne Quality Life Questionnaire 4 . Treatment Area Assessment Investigator Subjects discontinue baseline topical acne treatment 2 week washout and/or systemic acne treatment 3 week washout . All subject provide open label Cetaphil facial cleanser double-blind NAG vehicle product .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>1 . Male female age 12 2 . Has 10 inflammatory lesion face ( papule pustule ) determine qualified examiner Start Treatment . 3 . In area treat , significant facial dermatological condition acne ( determined investigator ) would interfere study treatment procedure 4 . Is willing able discontinue use baseline acne treatment duration trial participation 5 . Agrees refrain professional facial treatment trial participation . 6 . Agrees avoid tan booth use minimize sun exposure trial participation . 7 . Is willing able follow instruction procedure include attend schedule study visit , require adequate transportation study site 8 . Is able read , understand sign inform consent document communicate study staff investigator . If subject minor , parent document legal guardian must meet consent requirement subject must able understand , agree , sign assent form . 1 . Has 2 nodules/cystic acne lesion face 2 . Has history significant reaction topical acne treatment , know allergy hypersensitivity list ingredient 3 . Has history skin malignancy 4 . Has significant facial hair would interfere evaluation acne lesion global assessment . 5 . Has use systemic medication ( include antibiotic , estrogen , retinoids ) primarily treatment acne 21 day prior randomization . 6 . Has use estrogen primarily treatment acne 21 day prior randomization ( estrogens prescribe reason allow stable least 30 day prior randomization ) . 7 . Has professional facial treatment 14 day prior randomization . 8 . Has receive investigational treatment 30 day prior randomization . 9 . Have significant medical problem issue would , investigator 's judgment , affect suitability participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>